Predictions
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
28.04.24
28.04.24
-
28.04.25
28.04.25
5.22%
08.05.24
08.05.24
Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.22%
08.05.24
08.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€61.35
26.04.24
26.04.24
€79.45
26.04.25
26.04.25
-1.56%
08.05.24
08.05.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€122.60
26.04.24
26.04.24
€133.79
26.04.25
26.04.25
-1.63%
08.05.24
08.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€850.80
24.04.24
24.04.24
€962.84
24.04.25
24.04.25
4.54%
08.05.24
08.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.82
22.04.24
22.04.24
€131.54
22.04.25
22.04.25
-3.13%
08.05.24
08.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€843.20
20.04.24
20.04.24
-
20.04.25
20.04.25
5.48%
08.05.24
08.05.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€370.05
20.04.24
20.04.24
-
20.04.25
20.04.25
5.31%
08.05.24
08.05.24
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€62.71
20.04.24
20.04.24
€98.49
20.04.25
20.04.25
-3.70%
08.05.24
08.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
-1.02%
08.05.24
08.05.24